These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9142960)

  • 1. Insulin-like growth factors in breast cancer.
    Helle SI; Lønning PE
    Acta Oncol; 1996; 35 Suppl 5():19-22. PubMed ID: 9142960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, Pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients.
    Helle SI; Anker GB; Tally M; Hall K; Lønning PE
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):167-71. PubMed ID: 8645625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
    Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer.
    Reed MJ; Christodoulides A; Koistinen R; Seppälä M; Teale JD; Ghilchik MW
    Int J Cancer; 1992 Sep; 52(2):208-12. PubMed ID: 1381703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetate.
    Martinetti A; Zilembo N; Ferrari L; Massimini G; Polli A; La Torre I; Giovanazzi R; Pozzi P; Bidoli P; De Candis D; Seregni E; Bombardieri E; Bajetta E
    Anticancer Res; 2003; 23(4):3485-91. PubMed ID: 12926095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP; Leeding KS; Hu XF; DeLuise M; Zalcberg JR; Bach LA
    Breast Cancer Res Treat; 1999 Jun; 55(3):231-42. PubMed ID: 10517168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the secretion of insulin-like growth factor binding proteins -2 and -4 associated with the development of tamoxifen resistance and estrogen independence in human breast cancer cell lines.
    Maxwell P; van den Berg HW
    Cancer Lett; 1999 May; 139(2):121-7. PubMed ID: 10395168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
    Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
    Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical data for Droloxifene.
    Hasmann M; Rattel B; Löser R
    Cancer Lett; 1994 Sep; 84(2):101-16. PubMed ID: 8076367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factors and breast cancer.
    Lee AV; Yee D
    Biomed Pharmacother; 1995; 49(9):415-21. PubMed ID: 8746077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines.
    De Leon DD; Bakker B; Wilson DM; Hintz RL; Rosenfeld RG
    Biochem Biophys Res Commun; 1988 Apr; 152(1):398-405. PubMed ID: 2451917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.
    Mandalà M; Moro C; Ferretti G; Calabro MG; Nolè F; Rocca A; Munzone E; Castro A; Curigliano G
    Anticancer Res; 2001; 21(1B):585-8. PubMed ID: 11299809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patients.
    Grønbaek H; Tanos V; Meirow D; Peretz T; Raz I; Flyvbjerg A
    Anticancer Res; 2003; 23(3C):2815-20. PubMed ID: 12926118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of insulin-like growth factors and their binding proteins in the estrogen responsive Ishikawa human endometrial cancer cell line.
    Hana V; Murphy LJ
    Endocrinology; 1994 Dec; 135(6):2511-6. PubMed ID: 7527333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of insulin-like growth factor and its binding protein mRNA in the endometrium of postmenopausal patients with breast cancer receiving tamoxifen.
    Laatikainen TJ; Tomás EI; Voutilainen RJ
    Cancer; 1995 Oct; 76(8):1406-10. PubMed ID: 8620415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer.
    Yee D; Rosen N; Favoni RE; Cullen KJ
    Cancer Treat Res; 1991; 53():93-106. PubMed ID: 1672092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen.
    Howe SR; Pass HI; Ethier SP; Matthews WJ; Walker C
    Cancer Res; 1996 Sep; 56(17):4049-55. PubMed ID: 8752178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers.
    Michell NP; Langman MJ; Eggo MC
    Br J Cancer; 1997; 76(1):60-6. PubMed ID: 9218734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin-like growth factor system in advanced breast cancer.
    Helle SI
    Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):67-79. PubMed ID: 14687598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.